BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19347)

  • 21. [Histamine H2 receptor antagonists in gastroduodenal pathology].
    Puşcaş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):299-304. PubMed ID: 30144
    [No Abstract]   [Full Text] [Related]  

  • 22. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Histamine H2 receptor antagonists. Notes on clinical pharmacology].
    Pelosio L; Marasco A; Naim U
    Clin Ter; 1979 Nov; 91(4):421-7. PubMed ID: 44237
    [No Abstract]   [Full Text] [Related]  

  • 24. [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors].
    Bonfils S; Bernier JJ; Mignon M; Hautefeuille P; Corbic M; Marteau J
    Nouv Presse Med; 1975 Oct; 4(33):2377-81. PubMed ID: 653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cimetidine - an investigational drug for the treatment of duodenal ulcer.
    Med Lett Drugs Ther; 1977 Apr; 19(7):29-31. PubMed ID: 15200
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peptic ulcer: new aspects of conservative therapy].
    Bernoulli R
    Schweiz Med Wochenschr; 1977 May; 107(18):618-22. PubMed ID: 17157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of H2 antagonists in Zollinger-Ellison syndrome].
    Dammann HG; Walter TA; Müller P; Simon B
    Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
    [No Abstract]   [Full Text] [Related]  

  • 29. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of cimetidine on the treatment of acid-peptic disease.
    Fleshler B
    Prim Care; 1981 Jun; 8(2):195-203. PubMed ID: 7027288
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
    Piai G; Sabbatini F; Mazzacca G
    Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peptic ulcer: current therapy].
    Pieragnoli E
    G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387
    [No Abstract]   [Full Text] [Related]  

  • 33. [New class of pharmacological preparations: histamine H2-receptors blockaders (a review of the literature)].
    Ionov ID
    Farmakol Toksikol; 1978; 41(5):624-32. PubMed ID: 81139
    [No Abstract]   [Full Text] [Related]  

  • 34. Symposium on peptic ulcer disease: 4. Panel discussion on peptic ulcer disease.
    Perey BJ; Cohen MM; Doris PJ; Goligher JC; Jeejeebhoy KN
    Can J Surg; 1978 Jan; 21(1):26-7. PubMed ID: 620363
    [No Abstract]   [Full Text] [Related]  

  • 35. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitors of gastric secretion: current progress.
    Carter DC
    Br J Surg; 1976 Oct; 63(10):788-92. PubMed ID: 11030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy.
    McCarthy DM; Olinger EJ; May RJ; Long BW; Gardner JD
    Ann Intern Med; 1977 Dec; 87(6):668-75. PubMed ID: 22304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The present state of knowledge on the treatment of peptic diseases with cimetidine].
    Romankiewicz JA; Reidenberg MM
    Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.